Cannabinoid drug developer Inmed sets sights on partners

Inmed Pharmaceuticals Ltd., a Canadian-listed start-up mixing cannabinoids and noncannabis elements for the treatment of glaucoma is working to move into the clinic this year and attract the kind of big pharma backers that have rallied to support cannabinoid drugmaker GW Pharmaceuticals plc.